218 related articles for article (PubMed ID: 30029068)
1. Obesity and renal cell carcinoma risk by histologic subtype: A nested case-control study and meta-analysis.
Callahan CL; Hofmann JN; Corley DA; Zhao WK; Shuch B; Chow WH; Purdue MP
Cancer Epidemiol; 2018 Oct; 56():31-37. PubMed ID: 30029068
[TBL] [Abstract][Full Text] [Related]
2. An investigation of risk factors for renal cell carcinoma by histologic subtype in two case-control studies.
Purdue MP; Moore LE; Merino MJ; Boffetta P; Colt JS; Schwartz KL; Bencko V; Davis FG; Graubard BI; Janout V; Ruterbusch JJ; Beebe-Dimmer J; Cote ML; Shuch B; Mates D; Hofmann JN; Foretova L; Rothman N; Szeszenia-Dabrowska N; Matveev V; Wacholder S; Zaridze D; Linehan WM; Brennan P; Chow WH
Int J Cancer; 2013 Jun; 132(11):2640-7. PubMed ID: 23150424
[TBL] [Abstract][Full Text] [Related]
3. Renal cell cancer histological subtype distribution differs by race and sex.
Lipworth L; Morgans AK; Edwards TL; Barocas DA; Chang SS; Herrell SD; Penson DF; Resnick MJ; Smith JA; Clark PE
BJU Int; 2016 Feb; 117(2):260-5. PubMed ID: 25307281
[TBL] [Abstract][Full Text] [Related]
4. Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia.
Tickoo SK; dePeralta-Venturina MN; Harik LR; Worcester HD; Salama ME; Young AN; Moch H; Amin MB
Am J Surg Pathol; 2006 Feb; 30(2):141-53. PubMed ID: 16434887
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Value of Body Mass Index According to Histologic Subtype in Nonmetastatic Renal Cell Carcinoma: A Large Cohort Analysis.
Lee WK; Hong SK; Lee S; Kwak C; Oh JJ; Jeong CW; Kim YJ; Kang SH; Hong SH; Byun SS
Clin Genitourin Cancer; 2015 Oct; 13(5):461-8. PubMed ID: 25990340
[TBL] [Abstract][Full Text] [Related]
6. Genetic Variants Related to Longer Telomere Length are Associated with Increased Risk of Renal Cell Carcinoma.
Machiela MJ; Hofmann JN; Carreras-Torres R; Brown KM; Johansson M; Wang Z; Foll M; Li P; Rothman N; Savage SA; Gaborieau V; McKay JD; Ye Y; Henrion M; Bruinsma F; Jordan S; Severi G; Hveem K; Vatten LJ; Fletcher T; Koppova K; Larsson SC; Wolk A; Banks RE; Selby PJ; Easton DF; Pharoah P; Andreotti G; Freeman LEB; Koutros S; Albanes D; Mannisto S; Weinstein S; Clark PE; Edwards TE; Lipworth L; Gapstur SM; Stevens VL; Carol H; Freedman ML; Pomerantz MM; Cho E; Kraft P; Preston MA; Wilson KM; Gaziano JM; Sesso HS; Black A; Freedman ND; Huang WY; Anema JG; Kahnoski RJ; Lane BR; Noyes SL; Petillo D; Colli LM; Sampson JN; Besse C; Blanche H; Boland A; Burdette L; Prokhortchouk E; Skryabin KG; Yeager M; Mijuskovic M; Ognjanovic M; Foretova L; Holcatova I; Janout V; Mates D; Mukeriya A; Rascu S; Zaridze D; Bencko V; Cybulski C; Fabianova E; Jinga V; Lissowska J; Lubinski J; Navratilova M; Rudnai P; Szeszenia-Dabrowska N; Benhamou S; Cancel-Tassin G; Cussenot O; Bueno-de-Mesquita HB; Canzian F; Duell EJ; Ljungberg B; Sitaram RT; Peters U; White E; Anderson GL; Johnson L; Luo J; Buring J; Lee IM; Chow WH; Moore LE; Wood C; Eisen T; Larkin J; Choueiri TK; Lathrop GM; Teh BT; Deleuze JF; Wu X; Houlston RS; Brennan P; Chanock SJ; Scelo G; Purdue MP
Eur Urol; 2017 Nov; 72(5):747-754. PubMed ID: 28797570
[TBL] [Abstract][Full Text] [Related]
7. Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma.
Cheville JC; Lohse CM; Zincke H; Weaver AL; Blute ML
Am J Surg Pathol; 2003 May; 27(5):612-24. PubMed ID: 12717246
[TBL] [Abstract][Full Text] [Related]
8. Antihypertensive medication use and risk of renal cell carcinoma.
Colt JS; Hofmann JN; Schwartz K; Chow WH; Graubard BI; Davis F; Ruterbusch J; Berndt S; Purdue MP
Cancer Causes Control; 2017 Apr; 28(4):289-297. PubMed ID: 28224412
[TBL] [Abstract][Full Text] [Related]
9. Associations of Renal Cell Carcinoma Subtype with Patient Demographics, Comorbidities, and Neighborhood Socioeconomic Status in the California Population.
Lichtensztajn DY; Hofer BM; Leppert JT; Brooks JD; Chung BI; Shah SA; DeRouen MC; Cheng I
Cancer Epidemiol Biomarkers Prev; 2023 Feb; 32(2):202-207. PubMed ID: 36480301
[TBL] [Abstract][Full Text] [Related]
10. Obesity is associated with a higher risk of clear-cell renal cell carcinoma than with other histologies.
Lowrance WT; Thompson RH; Yee DS; Kaag M; Donat SM; Russo P
BJU Int; 2010 Jan; 105(1):16-20. PubMed ID: 19583732
[TBL] [Abstract][Full Text] [Related]
11. Histological subtype of renal cell carcinoma significantly affects survival in the era of partial nephrectomy.
Nguyen DP; Vertosick EA; Corradi RB; Vilaseca A; Benfante NE; Touijer KA; Sjoberg DD; Russo P
Urol Oncol; 2016 Jun; 34(6):259.e1-8. PubMed ID: 26947350
[TBL] [Abstract][Full Text] [Related]
12. Differences in risk factors for molecular subtypes of clear cell renal cell carcinoma.
Purdue MP; Rhee J; Moore L; Gao X; Sun X; Kirk E; Bencko V; Janout V; Mates D; Zaridze D; Petruzella S; Hakimi AA; Linehan WM; Chanock SJ; Brennan P; Furberg H; Troester M; Rothman N
Int J Cancer; 2021 Oct; 149(7):1448-1454. PubMed ID: 34058014
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of Clear Cell Renal Cell Carcinoma From Other Subtypes and Fat-Poor Angiomyolipoma by Use of Quantitative Enhancement Measurement During Three-Phase MDCT.
Kim SH; Kim CS; Kim MJ; Cho JY; Cho SH
AJR Am J Roentgenol; 2016 Jan; 206(1):W21-8. PubMed ID: 26700359
[TBL] [Abstract][Full Text] [Related]
14. Impact of histologic subtype on cancer-specific survival in patients with renal cell carcinoma and tumor thrombus.
Tilki D; Nguyen HG; Dall'Era MA; Bertini R; Carballido JA; Chromecki T; Ciancio G; Daneshmand S; Gontero P; Gonzalez J; Haferkamp A; Hohenfellner M; Huang WC; Koppie TM; Lorentz CA; Mandel P; Martinez-Salamanca JI; Master VA; Matloob R; McKiernan JM; Mlynarczyk CM; Montorsi F; Novara G; Pahernik S; Palou J; Pruthi RS; Ramaswamy K; Rodriguez Faba O; Russo P; Shariat SF; Spahn M; Terrone C; Vergho D; Wallen EM; Xylinas E; Zigeuner R; Libertino JA; Evans CP
Eur Urol; 2014 Sep; 66(3):577-83. PubMed ID: 23871402
[TBL] [Abstract][Full Text] [Related]
15. Understanding racial disparities in renal cell carcinoma incidence: estimates of population attributable risk in two US populations.
Callahan CL; Schwartz K; Corley DA; Ruterbusch JJ; Zhao WK; Shuch B; Graubard BI; Rothman N; Chow WH; Silverman DT; Purdue MP; Hofmann JN
Cancer Causes Control; 2020 Jan; 31(1):85-93. PubMed ID: 31782041
[TBL] [Abstract][Full Text] [Related]
16. Clear cell papillary renal cell carcinoma is the fourth most common histologic type of renal cell carcinoma in 290 consecutive nephrectomies for renal cell carcinoma.
Zhou H; Zheng S; Truong LD; Ro JY; Ayala AG; Shen SS
Hum Pathol; 2014 Jan; 45(1):59-64. PubMed ID: 24182559
[TBL] [Abstract][Full Text] [Related]
17. Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors after radical nephrectomy.
Dimarco DS; Lohse CM; Zincke H; Cheville JC; Blute ML
Urology; 2004 Sep; 64(3):462-7. PubMed ID: 15351571
[TBL] [Abstract][Full Text] [Related]
18. Effect of papillary and chromophobe cell type on disease-free survival after nephrectomy for renal cell carcinoma.
Beck SD; Patel MI; Snyder ME; Kattan MW; Motzer RJ; Reuter VE; Russo P
Ann Surg Oncol; 2004 Jan; 11(1):71-7. PubMed ID: 14699037
[TBL] [Abstract][Full Text] [Related]
19. Performance of Relative Enhancement on Multiphasic MRI for the Differentiation of Clear Cell Renal Cell Carcinoma (RCC) From Papillary and Chromophobe RCC Subtypes and Oncocytoma.
Young JR; Coy H; Kim HJ; Douek M; Lo P; Pantuck AJ; Raman SS
AJR Am J Roentgenol; 2017 Apr; 208(4):812-819. PubMed ID: 28125273
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of the Peritumoral Pseudocapsule Vary Predictably With Histologic Subtype of T1 Renal Neoplasms.
Jacob JM; Williamson SR; Gondim DD; Leese JA; Terry C; Grignon DJ; Boris RS
Urology; 2015 Nov; 86(5):956-61. PubMed ID: 26126697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]